- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/08 - Clostridium, e.g. Clostridium tetani
Patent holdings for IPC class A61K 39/08
Total number of patents in this class: 865
10-year publication summary
|
46
|
52
|
61
|
67
|
59
|
28
|
27
|
33
|
37
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2261 |
45 |
| Glaxosmithkline Biologicals S.A. | 1620 |
36 |
| Revance Therapeutics, Inc. | 126 |
25 |
| The University of Tokyo | 4297 |
17 |
| MERZ PHARMA GmbH & CO. KGaA | 605 |
15 |
| Pfizer Inc. | 3373 |
14 |
| Valneva Austria GmbH | 116 |
14 |
| The Regents of the University of California | 20410 |
13 |
| Wyeth LLC | 636 |
13 |
| University of Guelph | 372 |
12 |
| Wisconsin Alumni Research Foundation | 3924 |
11 |
| The Trustees of the University of Pennsylvania | 4387 |
10 |
| University of South Florida | 1860 |
8 |
| Sanofi Pasteur Inc. | 390 |
8 |
| Zoetis Services LLC | 1526 |
7 |
| Valneva USA, Inc. | 7 |
7 |
| Novartis AG | 10463 |
6 |
| The Regents of the University of Michigan | 4851 |
6 |
| The Board of Regents of the University of Oklahoma | 624 |
6 |
| Inovio Pharmaceuticals, Inc. | 325 |
6 |
| Other owners | 586 |